Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Burkitt Lymphoma 9Recurrence 8Leukemia 8Neoplasm, Residual 6Lymphoproliferative Disorders 6Lymphatic Diseases 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Immunoproliferative Disorders 4Neoplasms 3Leukemia, Lymphoid 2Neoplasms by Histologic Type 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Bites and Stings 1

Interventions

ponatinib 2pembrolizumab 2napabucasin 2ficlatuzumab 2entinostat 2Gemcitabine 2Bortezomib 2Bevacizumab 2130-nm albumin-bound paclitaxel 2tetulomab tetraxetan lu-177 1siltuximab 1ruxolitinib 1pralsetinib 1pamiparib 1nirogacestat 1interferon gamma-1b 1denileukin diftitox 1bosutinib 1blinatumomab 1Vorinostat 1Trabectedin 1Radiation 1Oncolytic Virotherapy 1Lutetium 1Leucovorin 1Irinotecan 1Interferon-gamma 1Immunotherapy 1Imatinib Mesylate 1HhAntag691 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms by Histologic Type × blinatumomab × Clear all
NCT01471782 2017-02-08

Clinical Study With Blinatumomab in Pediatric and Adolescent Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Amgen Research (Munich) GmbH

Phase 1/2 Completed
93 enrolled 21 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡